D. Rathbone

Y. Perrie, D. Lowry, P. Lambert, 2013, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Synthesis of potent water-soluble tissue transglutaminase inhibitors.

Richard A. Jones, R. Collighan, D. Rathbone, 2008, Bioorganic & medicinal chemistry letters.

Thiosemicarbazones active against Clostridium difficile.

P. Lambert, T. Karpanen, D. Rathbone, 2008, Bioorganic & medicinal chemistry letters.

New solid phase Knoevenagel catalyst

D. Billington, D. Rathbone, Julie Simpson, 1999 .

The crystal structure of first copper(II) complex of a pyridine-2-carboxamidrazone – a potential antitumor agent

S. Padhye, D. Billington, D. Rathbone, 2001 .

Molecular recognition by fluorescent imprinted polymers

D. Billington, David C. Billington, D. Rathbone, 2000 .

New Solid Phase Knoevenagel Catalyst.

D. Billington, D. Rathbone, Julie Simpson, 1999 .

Automated synthesis of anti‐cancer compounds

M. Tisdale, D. Billington, D. Rathbone, 1998 .

Metal complexes of carboxamidrazone analogs as antitubercular agents. 1. Synthesis, X-ray crystal-structures, spectroscopic properties and antimycobacterial activity against Mycobacterium tuberculosis H(37)Rv.

A. Powell, S. Franzblau, S. Padhye, 2002, Journal of inorganic biochemistry.

Discovery of a potent phenolic N1-benzylidene-pyridinecarboxamidrazone selective against Gram-positive bacteria.

M. Coleman, P. Lambert, Daniel L Rathbone, 2006, Bioorganic & medicinal chemistry letters.

Synthesis and characterization of copper(II) complexes of pyridine-2-carboxamidrazones as potent antimalarial agents

S. Croft, A. Powell, S. Padhye, 2003 .

Reaction profiling of a set of acrylamide-based human tissue transglutaminase inhibitors.

D. Rathbone, Mahmood H M Jasim, Mahmood H. M. Jasim, 2018, Journal of molecular graphics & modelling.

The differentiation of π- and τ-derivatised histidines

R. Colombo, A. Derome, D. Rathbone, 1985 .

The Regiospecific Alkylation of Histidine Side Chains

P. B. Wyatt, J. Jones, D. Rathbone, 1988 .

Isomorphous nucleosides with differing anti‐HIV activities

W. Fraser, D. Rathbone, N. Mahmood, 1998 .

P6.18 Activity of Thiosemicarbazone and Carboxamidrazone Compounds and Essential Oils Against Microorganisms Associated with Intravascular Device Related Infections

P. Lambert, T. Karpanen, D. Rathbone, 2006 .

Preliminary in vitro toxicological evaluation of a series of 2-pyridylcarboxamidrazone candidate anti-tuberculosis compounds III.

M. Coleman, P. Lambert, M D. Coleman, 1999, Environmental toxicology and pharmacology.

Functional characterization of two human receptor activity-modifying protein 3 variants

R. J. Bailey, D. Hay, D. Poyner, 2010, Peptides.

Catalysis by di-n-butyltin oxide of a tertiary ketol rearrangement: synthesis of intermediates and analogues of valine and isoleucine biosynthesis

D. Rathbone, D. Crout, 1987 .

A modified bonded model approach for molecular dynamics simulations of New Delhi Metallo-β-lactamase.

D. Rathbone, Amani A. Eshtiwi, 2023, Journal of molecular graphics & modelling.

Imidazolium-based warheads strongly influence activity of water-soluble peptidic transglutaminase inhibitors.

R. Collighan, D. Rathbone, M. Griffin, 2013, European journal of medicinal chemistry.

Synthesis and antimycobacterial activity of some heteroarylcarboxamidrazone derivatives.

M. Coleman, P. Lambert, P A Lambert, 1998, Drug design and discovery.

Towards a polymeric binding mimic for cytochrome CYP2D6.

Aisha Ali, Daniel L Rathbone, Polyxeni Antonaki, 2005, Biosensors & bioelectronics.

Effect of catechol derivatives on cell growth and lipoxygenase activity.

M. Tisdale, D. Billington, D. Rathbone, 2003, Bioorganic & medicinal chemistry letters.

Selectivity of response in fluorescent polymers imprinted with N1-benzylidene pyridine-2-carboxamidrazones

Y. Ge, D. Rathbone, 2001 .

Development of Potent and Selective Tissue Transglutaminase Inhibitors: Their Effect on TG2 Function and Application in Pathological Conditions.

S. El Alaoui, C. Murdoch, D. Rathbone, 2015, Chemistry & biology.

Development of Potent and Selective Tissue Transglutaminase Inhibitors : Their Effect on TG 2 Function and Application in Pathological Conditions Graphical Abstract Highlights

C. Murdoch, D. Rathbone, M. Griffin, 2022 .

Structural studies on bioactive compounds. 28. Selective activity of triazenyl-substituted pyrimethamine derivatives against Pneumocystis carinii dihydrofolate reductase.

M. Stevens, P. Lambert, S. Queener, 1997, Journal of Medicinal Chemistry.

Characterization of Heparin-binding Site of Tissue Transglutaminase

Xiaoling Li, R. Collighan, D. Rathbone, 2012, The Journal of Biological Chemistry.